Top JP­Mor­gan in­vest­ment banker brings his tal­ents — and con­nec­tions — to the biotech start­up crew on board Flag­ship

Stephen Beren­son had a 33-year run at JP­Mor­gan be­fore he stepped out as vice chair­man of in­vest­ment bank­ing at the be­gin­ning of the year. By his own ac­count, the 57-year-old had tak­en any num­ber of com­pa­nies pub­lic, worked any num­ber of M&A deals.

But he want­ed to do “some­thing com­plete­ly new and com­plete­ly trans­for­ma­tive.”

So to­day you can wel­come him to the biotech world.

Beren­son is Noubar Afeyan’s lat­est top re­cruit at Flag­ship Pi­o­neer­ing, the start­up ven­ture group that likes to launch 7 or 8 or 9 new plat­form com­pa­nies a year, all of which are look­ing to do some­thing new and com­plete­ly trans­for­ma­tive in biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER